Pain
Pain Neuroscience news articles cover science research about pain receptors, nociceptors, nociception, sensory neurons, somatosensory cortex, chronic pain, acute pain, nocioceptors, musculoskeletal pain, therapies, phantom limb pain and other pain research.
Researchers reveal a neurotransmitter implicated in the itch sensation plays no role in the transmission of pain sensations.
Discovery could pave the way for new treatments for chronic pain in humans, researchers report.
Brinker-related transcription regulators play a key role in the formation of nociceptive sensation and could be a new target for pain-relieving medications.
Conolidine, a natural pain killer derived from the pinwheel flower and frequently used in Chinese medicine, interacts with a newly identified opioid receptor that regulates natural opioid peptides produced in the brain.
MRC1+ macrophages are dysfunctional in animal models of neuropathic pain. Stimulating the expression of the anti-inflammatory protein CD163 reduced signs of neuroinflammation in the spinal cords of mice with neuropathic pain.
Hydrafil, an experimental injectable hydrogel appears to be safe and effective in reducing chronic lower back pain associated with degenerative disc disease.
A newly developed peptide called Tat-P4-(C5)2 is targets and only affects nerve changes that pose a problem resulting in chronic pain. Previous studies have also shown the peptide can also reduce addiction.
Researchers report activating a pathway between the amygdala and brain stem helps to relieve pain and reduce defensive behaviors in rat models.
Compared to opioid use alone, co-use of cannabis and opioids to treat pain is associated with increased anxiety and depression symptoms in adults.
Cognitive behavioral therapy for pain that is supported by artificial intelligence renders the same results as guideline-recommended programs while requiring less clinician time, thus making the option more accessible for patients.
